Prolonged low doses of oral etoposide may be effective in individual patients with advanced lymphoproliferative disorders refractory to aggressive chemotherapy

MeSH terms

• Administration, Oral
• Adult
• Aged
• Antineoplastic Agents, Phytogenic / administration & dosage*
• Antineoplastic Agents, Phytogenic / adverse effects
• Antineoplastic Agents, Phytogenic / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Drug Evaluation
• Etoposide / administration & dosage*
• Etoposide / adverse effects
• Etoposide / therapeutic use
• Female
• Hematologic Neoplasms / drug therapy*
• Hematologic Neoplasms / pathology
• Humans
• Male
• Middle Aged
• Remission Induction
• Salvage Therapy*